The Molecular Profiling Lottery: More Accuracy, Less Precision, and No Cost.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30514776.
- Also identified by DOI 10.1158/1078-0432.CCR-18-3513.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The concept of complete molecular profiling to select investigational treatment options is appealing, theoretically allowing the matching of patients to investigational drugs specifically targeted to molecular features of each patient's cancer. Although some patients do benefit from such a strategy, the vast majority do not.See related article by Tuxen et al., p. 1239.
Medical subject headings
- Neoplasms